Luis Valverde-Jaramillo

Huancayo, JUN, Peru

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Correction: Jaramillo-Valverde et al. Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru. 2025; 17(3): 40566.

Correction: Jaramillo-Valverde et al. Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru. 2025; 17(3): 40566.

Journal: Frontiers in bioscience (Scholar edition)
Published: January 14, 2026

Molecular Epidemiology of GSTM1 and GSTT1 Null Genotypes in High-Altitude Andean Populations of Peru.

Molecular Epidemiology of GSTM1 and GSTT1 Null Genotypes in High-Altitude Andean Populations of Peru.

Journal: International journal of molecular sciences
Published: January 08, 2026

Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru.

Exploratory Study on Genetic Variants Related to Hydatidosis Susceptibility and Albendazole Pharmacogenetics in the Cusco Region in Peru.

Journal: Frontiers in bioscience (Scholar edition)
Published: May 08, 2025

The peruvian genome project: expanding the global pool of genome diversity from South America.

The peruvian genome project: expanding the global pool of genome diversity from South America.

Journal: Frontiers in genetics
Published: April 18, 2025

From Womb to World: Unravelling the Microbiota's Impact on Health and Disease.

From Womb to World: Unravelling the Microbiota's Impact on Health and Disease.

Journal: International journal of microbiology
Published: March 15, 2025

Pharmacogenetic Study of Anti-TB Drugs in the Native Ancestry Peruvian Population.

Pharmacogenetic Study of Anti-TB Drugs in the Native Ancestry Peruvian Population.

Journal: Pharmacology research & perspectives
Published: January 04, 2025

Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations.

Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations.

Journal: Pharmacology research & perspectives
Published: October 05, 2023

Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis Infection.

Antigen-Induced IL-1RA Production Discriminates Active and Latent Tuberculosis Infection.

Journal: Microorganisms
Published: March 18, 2023

A mobile lab for ancient DNA extraction in Perug.

A mobile lab for ancient DNA extraction in Perug.

Journal: Bioinformation
Published: November 01, 2022

GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients.

GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients.

Journal: International journal of molecular sciences
Published: August 15, 2022

CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration.

CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration.

Journal: Cureus
Published: December 30, 2021

NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients.

NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients.

Journal: Molecular genetics & genomic medicine
Published: November 21, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026